Respiratory

Guidelines (13)

Mepolizumab for Treating Severe Refractory Eosinophilic Asthma (TA431)

25 January 2017

Management of Asthma in Adults (BTS/SIGN Guideline)

22 November 2016

Summary of BTS/SIGN protocol for asthma treatment in adults.

Management of Asthma in Children (BTS/SIGN Guideline)

22 November 2016

Summary of BTS/SIGN protocol for asthma treatment in children.

Lumacaftor-Ivacaftor for Treating Cystic Fibrosis Homozygous for the F508del Mutation (TA398)

27 July 2016

Nintedanib for Treating Idiopathic Pulmonary Fibrosis (TA379)

29 January 2016

Pirfenidone for Treating Idiopathic Pulmonary Fibrosis (TA282)

24 April 2013

Omalizumab for Treating Severe Persistent Allergic Asthma (TA278)

24 April 2013

Mannitol Dry Powder for Inhalation for Treating Cystic Fibrosis (TA266)

28 November 2012

Roflumilast for the Management of Severe Chronic Obstructive Pulmonary Disease (TA244)

23 February 2012

COPD: Management in Adults (NICE)

28 June 2010

Summary of NICE guidance on COPD treatment.

Load More

Respiratory in the News

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

27 March 2017

Available presentations of bronchodilators and anti-inflammatories.

Inhalers, a Guide to Breath-Actuated Devices

Inhalers, a Guide to Breath-Actuated Devices

27 March 2017

Key features of dry powder and aerosol inhalers.

Alternative salmeterol/fluticasone dry powder inhaler for asthma and COPD

Alternative salmeterol/fluticasone dry powder inhaler for asthma and COPD

By Chloe Harman, 13 March 2017

Aerivio Spiromax provides the same metered dose of salmeterol/fluticasone propionate as Seretide 500 Accuhaler, and is indicated for use in adults with asthma and COPD.

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Report an adverse event